Cipla acquires 2 US generic companies


Cipla, a major generic firm based out of India, has announced that it has acquired two US generic drug makers for $550 million. The company acquired InvaGen Pharmaceuticals and Exelan Pharmaceuticals, and is expected to help boost Cipla’s US business.

Read the source article at IBTimes India

About the Author

Related Posts

Leave a Reply